Overview

Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream

Status:
Completed
Trial end date:
2019-12-19
Target enrollment:
Participant gender:
Summary
To compare the relative efficacy and safety and of 5-FU Cream to the marketed formulation Efudex® (5-FU) Cream, and to demonstrate the superior efficacy of the two active formulations over that of the Vehicle Control Cream, in the treatment of actinic keratosis.
Phase:
Phase 3
Details
Lead Sponsor:
Sol-Gel Technologies, Ltd.
Treatments:
Fluorouracil